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Recreational, intermittent sun exposure is believed to be the main
environmental risk factor for cutaneous melanoma (hereafter
referred as ‘melanoma’) (IARC, 1992; Elwood and Jopson, 1997).
If ultraviolet radiation (UV) seems to represent the part of the solar
spectrum involved in melanoma occurrence, the respective role 
of ultraviolet B (UVB, 280–315 nm) and ultraviolet A (UVA,
315–400 nm) radiation in melanoma genesis is still unknown
(Setlow and Woodhead, 1994; Donawho and Wolf, 1996).
During the summer 1997, in a double-blind randomized trial
with European participants aged 18 to 24 years old, we demon-
strated that use of high sun protection factor (SPF) sunscreen could
lead to longer stays in the sun (Autier et al, 1999). The SPF is a
measure of the ability of a sunscreen product to delay sun-induced
sunburns. That phenomenon may explain why in epidemiological
studies, sunscreen use during sunbathing was often associated with
a higher risk of melanoma, basal cell skin cancer or higher nevi
count (Bigby, 1999; Autier, 2000). However it is not known which
aspect of prolonged sun exposure is responsible for the increased
melanoma risk, e.g. UVA exposure (Lui et al, 1997).
In this study, which reproduced the double-blind randomized
design of summer 1997, we used personal UV-dosimeters to
examine how, in the usual conditions of their use sunscreens of
different SPF would influence exposure to UVB and UVA radia-
tion.
This study focused on sunbathing since, as shown during the
1997 trial, use of higher SPF sunscreen led to longer sunbathing
(Autier et al, 1999). Also, the average European adult vacationer
more often uses sunscreens for sunbathing than for other outdoor
activities. Moreover sunbathing is typical of the intermittent sun
exposure pattern, and a known risk factor for cutaneous melanoma
in white European populations (Autier et al, 1994; Osterlind et al,
1988).
METHODS
The personal UV-dosimeters used in this trial were genuine proto-
types. Because of their cost, only 50 personal dosimeters were
available, and we could therefore not conduct a trial with a sample
size as large as during the summer 1997 when 86 participants were
randomized. 12 participants without personal UV-dosimeter were
nonetheless further recruited in order to increase statistical power,
so that we could determine whether the previous findings could be
reproduced with participants originating from different environ-
ments and having vacations in different places.
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Summary A previous randomized trial found that sunscreen use could extend intentional sun exposure, thereby possibly increasing the risk
of cutaneous melanoma. In a similarly designed trial, we examined the effect of the use of sunscreens having different sun protection factor
(SPF) on actual exposure to ultraviolet B (UVB) and ultraviolet A (UVA) radiation. In June 1998, 58 European participants 18–24 years old
were randomized to receive a SPF 10 or 30 sunscreens and were asked to complete daily records of their sun exposure during their summer
holidays of whom 44 utilized a personal UVA and UVB dosimeter in a standard way during their sunbathing sessions. The median daily
sunbathing duration was 2.4 hours in the SPF 10 group and 3.0 hours in the SPF 30 group (P = 0.054). The increase in daily sunbathing
duration was paralleled by an increase in daily UVB exposure, but not by changes in UVA or UVB accumulated over all sunbathing sessions,
or in daily UVA exposure. Of all participants, those who used the SPF 30 sunscreen and had no sunburn spent the highest number of hours
in sunbathing activities. Differences between the two SPF groups in total number of sunbathing hours, daily sunbathing duration, and daily
UVB exposure were largest among participants without sunburn during holidays. Among those with sunburn, the differences between the two
groups tended to reduce. In conclusion, sunscreens used during sunbathing tended to increase the duration of exposures to doses of
ultraviolet radiation below the sunburn threshold. © 2000 Cancer Research Campaign
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of Cancer.Trial design
The design, randomization method, questionnaires, commercial
sunscreens used, sunscreen repackaging, selection and
informing of participants strictly followed the summer 1997
trial design (Autier et al, 1999). In brief, in June 1998, 62
Belgian and French paid participants 18–24 years old were
randomized to receive a SPF 10 or a SPF 30 sunscreen (320 g
per volunteer). Participants were asked to record their sun expo-
sure in standard record diaries on a daily basis. In order to keep
the trial as close as possible to habitual conditions of sun-
bathing, no specific recommendation was made about sun ex-
posure or sunscreen use. The stated trial endpoint for
participants and medical personal who had direct contacts with
them was the number of pigmented skin lesions before and after
the holidays.
The trial was implemented in three institutions not involved in
the summer 1997 trial: the St Louis hospital (Paris, France, 16
participants randomized), the Beauregard hospital (Thionville, a
town located in the North of France, 16 participants randomized),
and the Jules Bordet Institute (Brussels, Belgium, 30 participants
randomized). The study was conducted in accordance with the
principles of the Helsinki declaration, and was submitted for
approval to the Ethical Review Committee of each participating
institution. Each volunteer signed a written informed consent
before randomization.
Personal dosimeters
The dosimeter dimensions were 9.5 × 6.0 × 2.5 cm. It comprised
on its largest surface a UVB and a UVA captor, able to record
100% radiation within an angle of 60 degrees (Laser Components
GmbH, Olching, Germany). The UVA captor had its maximal
sensitivity for the 340 nm wavelength, and had a sensitivity ≥ 10%
of the maximal sensitivity from 315 to 395 nm. The UVB captor
had its maximal sensitivity for the 270 nm wavelength, and had a
sensitivity ≥ 10% of the maximal sensitivity from 240 to 310 nm.
These captors were heat stable and water-resistant (but not water-
proof). Every 20 minutes, the recorded UVB and UVA were stored
in the memory. UV recording was automatic and permanent.
Participants had not to manoeuvre any button to start the
dosimeter. A lithium battery ensured 3-month power autonomy.
Time recording corresponded to the so-called Continental summer
hour, equivalent to the solar hour plus 2 hours. A port inserted in
the dosimeter allowed data transfer to a computer database using
custom software.
The dosimeters were calibrated using recommendations from
the American Conference of Governmental Industrial Hygienists
issued in 1997. Details on calibration procedure may be obtained
from the authors.
Random allocation of dosimeters and instruction to
participants
Personal dosimeters were given to participants during the initial
visit in June 1998, on the basis of ‘first come – first served’.
Participants received standard instructions on how to use the
dosimeter: when sunbathing, they had to install the dosimeter
nearby them in the sunlight with captors oriented horizontally to
the ground.
Data analysis
For each day, a question in the standard record diaries specifically
inquired about the type of sun exposure that took place at a given
moment of the day. Each time a volunteer reported a sunbathing
activity, he or she had to indicate the starting and ending hour.
Sunbathing duration was derived from the daily record diaries. UV
exposure was derived from the dosimeters.
Sun induced erythemal reaction is essentially due to the UVB
radiation. Throughout the analysis, UVB exposure is expressed in
terms of minimal erythemal dose (MED, with 1 MED being
equivalent to 200 J/m2). One MED is the lowest radiant exposure
to UVR that is sufficient to produce erythema with sharp margins
24 hours after exposure (IARC, 1992). In this trial, a skin
erythema had to be painful for being considered as sunburn.
Depending on individual sun sensitivity, sunburn occurs after UV
exposure equivalent to 2 to 4 MEDs.
The distribution of sun exposure duration and UV exposure,
being skewed to the right, departed from Gaussian distribution.
Also, during analysis, small numbers of participants were encoun-
tered in some strata. Therefore, when not otherwise specified,
medians and inter quartile ranges were used for presenting
summary statistics. In the latter case, non-parametric tests were
used for testing differences in data distribution between the two
randomization groups. When means were used as summary statis-
tics, the student t-test or the analysis of variance methods were
used to test differences. Least-squares regression multivariate
analysis was used to assess the influence of different factors on
study end points, after log transformation of endpoints. All statis-
tical tests were two-sided.
RESULTS
The randomization process allocated 31 participants in the SPF 10
group and 31 participants in the SPF 30 group. One volunteer in
the SPF 10 group (without dosimeter) had a car accident when
going on holiday, and could not take part in the trial. Three partic-
ipants, one in the SPF 10 arm (who had a dosimeter) and two in the
SPF 30 arm (who had a dosimeter), did not sunbathe during their
holidays, because of bad weather or sickness. Hence, for these four
participants, no data on sunbathing and related UV exposure could
be taken into account.
Distributions by sex, study place and skin phototypes were equiva-
lent in both randomization arms (Table 1). Fifty-five per cent of areas
where SPF 10 participants spent their holidays were located on the
Mediterranean coast, 13% in tropical or subtropical zones, and 32%
were in the countryside or on the North Sea coast. These proportions
were 60, 10 and 30% for SPF 30 participants, respectively.
Mean (range) use of sunscreens by participants was 67 (13–
128) g in the SPF 10 group and 77 (2–178) g in the SPF 30 group
(Student t-test P = 0.22). A sunscreen other than the one offered was
used during 5% and 6% of days with sun exposure in the SPF 10 and
SPF 30 group, respectively (χ 2 test: P > 0.50). History of sunburns
during holidays was equivalent in the two groups (Table 1).
The dosimeters of 6 participants did not provide relevant infor-
mation (Table 1), so UV recordings were informative for 23 SPF
10 and 21 SPF 30 participants. The distribution of skin phototype
was equivalent in the two groups of participants with a dosimeter
and carrying a dosimeter seemed not to have affected either
sunburn experience or quantities of sunscreen used (data not
shown). In both groups, participants used the dosimeter during
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to bring the dosimeter to the beach, or they sunbathed in swim-
ming pools, and preferred not to use the dosimeter because of the
proximity of the water. There was no indication in the diaries that
amounts of UV exposure were different during days with or
without use of the dosimeter.
Use of the SPF 30 sunscreen was associated with a 25%
increase in duration of daily sunbathing (Table 2). A slightly larger
difference in duration was noticeable for sunbathing activities
before 6 PM (i.e., 4 PM solar hour). In order to control for poten-
tial confounding effects, we fitted a linear regression model with
daily sunbathing duration as dependant variable. The SPF (10
versus 30), the in-trial sunburn experience (none versus ≥ 1), the
skin phototype (I–II versus III), and the quantity of sunscreen 
used (continuous variable) were the independent variables. The
adjusted extra time spent in sunbathing activities when the SPF 30
sunscreen was used was 33 minutes (95% confidence interval: 3 to
63 minutes, P = 0.020).
The starting hour of sunbathing activities was identical in both
groups during the first two holiday days with sunbathing (Figure
1). As holidays progressed, however, SPF 30 participants tended to
start sunbathing systematically earlier in the day, while SPF 10
participants tended to start sunbathing systematically later in the
day. As a consequence, sunbathing after 6 PM was more prevalent
among SPF 10 participants (Table 2), who were apparently more
inclined to take advantage of the sunniest days for sunbathing
longer during the late afternoons and evenings.
Differences in the timing of sunbathing between the two groups
(Table 2 and Figure 1) had effects on UVA and UVB exposure:
according to dosimeters (Figure 2), most intense exposures before
2 PM found among SPF 30 participants. After 4 PM SPF 10
participants had more intense exposure to UV, particularly UVA.
In both groups, UVA and UVB received by participants did not
parallel typical proportions of UVA and UVB reaching earth’s
surface over the day in a Mediterranean area (shown in the lower
part of Figure 2).
The total UVA and UVB exposure accumulated during all
sunbathing sessions were quite similar in both groups (Table 2),
but with substantial interindividual variation. Taking 1 MED
equivalent to 200 J/m2 of UVB (IARC, 1992), sunbathing activi-
ties during summer 1998 holidays were associated with an average
accumulated UVB exposure of ~42 MEDs after correction for
days without dosimeter.
Data in Table 2 show that it was the increase in median UVB
exposure per day with sunbathing that best paralleled the increase
in daily sunbathing duration of SPF 30 participants. No, or smaller
difference emerged between the two groups for accumulated and
daily UVA exposure.
In epidemiological studies, the largest difference in melanoma
risk (or in nevi count) between sunscreen users and non-users 
was found among subjects without sunburn history (Autier et al,
1995, 1998; Westerdahl et al, 2000). We therefore analysed data
according to sunburn experience during the trial (Table 3). The
largest differences in total number of sunbathing hours on holi-
days, and in daily sunbathing duration was observed among partic-
ipants who did not suffer from sunburn on holidays. These
differences were statistically significant in spite of the small
number of participants in each category of sunburn by SPF group.
SPF 30 participants without sunburn spent the highest number of
hours in sunbathing activities. When sunburn was experienced
during holidays, the total and daily sunbathing duration tended to
become equivalent in the two groups. In a linear regression model
with the total number of sunbathing hours as endpoint, a positive
interaction with an associated P value of 0.08 became apparent
between use of a SPF 30 sunscreen and the absence of sunburn.
Amounts and differences in accumulated UVB over holidays
did not correlate, whereas daily UVB exposure correlated well,
with sunburn experience (Table 3). In the SPF 10 group, a median
daily UVB dose of 511 J/m2 (i.e., ~2.5 MEDs) had no consequence
in terms of sunburn. An increase in sunbathing duration of 0.7
hours per day, representing a median extra daily UVB exposure of
~1.5 MEDs, was associated with one sunburn episode in the SPF
10 group, but not in the SPF 30 group. Participants in the latter
group had to accrue a supplementary UVB dose of ~ 1MED before
getting a sunburn, indicating that compared to SPF 10 participants,
SPF 30 participants could stand higher daily doses of
UVB without incurring sunburn. However, when a median daily
UVB exposure of ~5 MEDs was reached, sunburn occurrence was
the rule, irrespective of the SPF used.
The distribution of accumulated, or of daily UVA exposure did
not correlate with differences observed for daily sunbathing
duration or for in-study sunburn experience.
DISCUSSION
This double blind, randomized trial conducted during summer 1998
confirmed the main findings of the trial conducted during summer
1997 (Autier et al, 1999). Quantities of sunscreen used were
similar. Duration of sunbathing in both groups, as well as the differ-
ence in daily sunbathing duration between groups, were nearly
equal to those observed in 1997. Earlier starting hour of sunbathing
activities with use of the SPF 30 sunscreen was also achieved as
well as similar sunburn experience in the two groups. However,
because of restricted availability of dosimeters, the sample size in
1998 was smaller than in 1997. As a consequence, results obtained
in 1998 had lower statistical significance than those obtained in
1997, and there was more instability in the data.
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Table 1 Characteristics of participants
SPF 10a SPF 30
(n = 29) (n = 29)
French, Paris 8 7
French, Thionville 7 7
Belgian, Brussels 14 15
Females 20 23
Males 9 6
Skin Phototypeb
I1 2
II 15 16
III 13 11
Number of participants with
No sunburn episode during the trial 12 11c
1 sunburn episode during the trial 10 7
≥ 2 sunburn episodes during the trial 7 11
Participants who received a dosimeter 26 24
Participants with informative dosimeter 23 21
Did not sunbathe 1 2
Did not use the dosimeter 0 1
Defective dosimeter 2 0
a SPF: Sun Protection Factor; b When going in the sun, skin phototype I
always burns and never tans; skin phototype II always burns first and tans
after; skin phototype III sometimes burns but always get a deep tan
(Fitzpatrick, 1988); c χ 2 of heterogeneity: P = 0.46.Some investigations have attempted to assess UV-light expo-
sure of humans using biophysical methods (Dwyer et al, 1996;
Diffey et al, 1996; Creech and Mayer, 1997), but to the best of our
knowledge, this is the first study to assess UV exposure during
sunbathing, an intermittent sun exposure pattern known to be
associated with melanoma occurrence in Europe. In spite of the
aforementioned limitations in statistical power, our results provide
some insights into the relationship between intentional sun
exposure and UV exposure.
We examined the extent to which technical aspects of the
dosimeters or the way they were used could explain the results.
Instructions given to participants for recording UV exposure
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Table 2 Duration of sunbathing and exposure to UVB and UVA radiation
SPF 10a SPF 30 % Change P value
All participants
Total number of days with sunbathing for all participants 245 237 ––
Range 1–20 3–16
Hours of sunbathing per day with sunbathing
All sunbathing sessions
Median 2.4 3.0b + 25% 0.054
1st–3rd quartile 2.0–3.1 2.5–4.0
Sunbathing ≤ 6 PM
Median 2.1 2.8c + 33% 0.028
1st–3rd quartile 1.6–3.1 2.5–3.8
Number of days with sunbathing that ended ≥ 6 PM 110 70 – 34%
% of total days with sunbathing 45% 29% < 0.01b
Participants with informative dosimeters
UVB (Joules/m2) during sunbathing sessions with dosimeter
Accumulated UVB exposure during holidays
Median per volunteer 5891 5863 – 0.5 0.40
Range 273–16 829 2165–19 163
Median UVB exposure per day with sunbathingc
Daily exposure 841 984 + 17 0.15
1st–3rd quartile 532–1132 837–1192
Daily exposure ≤ 6 PM 781 984 + 26 0.12
1st–3rd quartile 483–1046 798–1187
UVA (KJoules/m2) during sunbathing sessions with dosimeter
Accumulated UVA exposure during holidays
Median per volunteer 727 812 + 11 0.70
Range 365–2399 274–3528
Median UVA exposure per day with sunbathingc
Daily exposure 136 125 – 8 0.50
1st–3rd quartile 89–176 93–187
Daily exposure ≤ 6 PM 135 124 – 8 0.39
1st–3rd quartile 87–167 90–186
a SPF: Sun Protection Factor; b χ 2 test; c Denominator is the number of days with sunbathing during which the dosimeter was used.
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Figure 1 Mean hour of start of sunbathing activities in days with
sunbathing. Days without sunbathing were skipped. The time in the figure is
the so-called ‘summer hour’ in Continental Europe, equivalent to the solar
hour plus 2 hours. Blank squares represent SPF 30 participants; black circles
represent SPF 10 participants. Linear regression lines have been drawn for
each group using least square regression model. Student t-test for the
difference in mean hours between the two groups: t = 4.8 with 24 degrees
of freedom: P < 0.001
Figure 2 Average daily doses of UVA and UVB received by participants
during different periods of the day. The time in the figure is the so-called
‘summer hour’ in Continental Europe, equivalent to the solar hour plus 2
hours. The lower part of the figure shows typical proportions of UVA and UVB
reaching earth’s surface over a clear sky summer day in a Mediterranean
area, at 40 degrees of Northern latitude (Diffey, 1991, adapted)during sunbathing sessions mimicked the measure of horizontal
solar irradiance commonly utilized for producing the ‘solar UV-
index’ (ICNIRP, 1995; Geller et al, 1997; Jendritzky et al, 1997).
As the UVA sensor had a smaller aperture angle than the UVB
sensor, when the dosimeter veered off the sun, the UVA signal
could drop more quickly than the UVB signal. This effect was
normally more prevalent before 10 am or after 6 pm when the sun
is closer to the horizon. Data in Figure 2 may suggest the presence
of that angular effect early in the morning and late in the after-
noon. However, there is no reason to believe that this angular
effect was not equally distributed among the two randomization
groups.
The difference in daily sunbathing duration correlated with
differences in daily UVB exposure, but not with UVA or UVB
exposure accumulated over all sunbathing sessions, or with daily
UVA exposure. UVA irradiation throughout the day is more
constant than UVB irradiation, and the UVB-to-UVA ratio in the
solar spectrum is maximal around noon (IARC, 1992), i.e., around
2 pm in this trial (Figure 2). Results from this trial and from the
1997 trial (Autier et al, 1999) suggest that use of the SPF 30
sunscreen encouraged participants to sunbathe when UVB
irradiation was maximal. In contrast, SPF 10 participants seemed
keener to sunbathe later in the afternoon, when sunlight was less
intense, that is, less rich in UVB radiation. Hence, proportionally
to daily UVA exposure, SPF 30 participants were exposed to
greater amounts of daily UVB than SPF 10 participants.
The largest differences between the two groups with regards to
total number of sunbathing hours on holiday, daily sunbathing
duration, and daily UVB exposure, were observed in participants
who did not suffer from sunburn. Although only of borderline
statistical significance, the positive interaction found between in-
trial sunburn experience and randomization group suggested that
absence of sunburn due to sunscreen use encourages extension of
intentional sun exposure.
Sunburn is an inflammatory process of the skin essentially
induced by UVB radiation. The ‘sunburn threshold’ (the quantity
of UV in one day needed to trigger a sunburn) is lowest in subjects
highly sun sensitive, and highest in subjects who never burn and
tan easily when in the sun. In this trial, and in the 1997 trial (Autier
et al, 1999), participants in both groups had similar sunburn expe-
rience during their holidays. This finding suggests that the UV
delivered to the skin below the sunscreen layer was similar in both
groups. The two groups differed in the way the daily UV doses
were delivered to the skin. Sunscreen use during sunbathing would
set the individual sunburn threshold at a higher level. Because of
the longer time needed to reach the higher sunburn threshold,
increase in time spent in sunbathing activities was possible, espe-
cially if no sunburn occurred. Bearing in mind that the greatest
difference in melanoma risk or nevi count between sunscreen users
and non-users was found in subjects free of sunburn history
(Autier et al, 1995, 1998; Westerdahl et al, 2000), our results
suggest that the association between sunscreen use and melanoma
Sunscreen use and UVB/UVA exposure 1247
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Table 3 Sunbathing and exposure to UVB and UVA radiation according to sunburn experience during holidays
SPF 10a SPF 30 % Change P value
All participants
Median total number of hours of sunbathing ≤ 6 PM
No sunburn episode 11.5 25.0 + 174 0.06
1 sunburn episode 18.5 17.0 – 8 0.92
≥ 2 sunburn episodes 17.0 19.0 + 11 0.89
Median total number of hours of sunbathing > 6 PM
No sunburn episode 2.0 0.0 – 200 0.04
1 sunburn episode 1.5 1.0 – 33 0.96
≥ 2 sunburn episodes 2.0 1.0 – 50 0.30
Median number of hours of sunbathing per day with sunbathing
No sunburn episode 2.1 3.0 + 43 0.026
1 sunburn episode 2.8 3.2 + 14 0.41
≥ 2 sunburn episodes 3.0 3.0 0 0.62
Median number of hours of sunbathing ≤ 6 PM per day with sunbathing
No sunburn episode 1.9 2.7 + 42 < 0.01
1 sunburn episode 2.6 2.8 + 8 0.59
≥ 2 sunburn episodes 3.0 3.0 0 0.36
Participants with informative dosimeter
UVB during sunbathing sessions ≤ 6 PM
Median accumulated UVB during sunbathing (Joules/m2)
No sunburn episode 3896 5620 + 44 0.23
1 sunburn episode 5473 3858 – 30 0.69
≥ 2 sunburn episodes 5633 6856 + 22 0.71
Median UVB exposure per day with sunbathing (Joules/m2)b
No sunburn episode 511 889 + 74 0.08
1 sunburn episode 828 1095 + 32 0.41
≥ 2 sunburn episodes 1046 1102 + 5 0.58
UVA during sunbathing sessions ≤ 6 PM
Median accumulated UVA during sunbathing (KJoules/m2)
No sunburn episode 718 739 + 3 0.77
1 sunburn episode 727 587 – 19 0.81
≥ 2 sunburn episodes 1489 1060 – 29 0.58
Median UVA exposure per day with sunbathing (KJoules/m2)b
No sunburn episode 90 108 + 20 0.85
1 sunburn episode 141 104 – 26 0.81
≥ 2 sunburn episodes 140 163 + 16 0.47
a SPF: Sun Protection Factor; b Denominator is the number of days with sunbathing during which the dosimeter was used 1248 P Autier et al
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would proceed from the ability of sunscreens to allow the repeti-
tion over short periods of exposures to UV doses below the
sunburn threshold. This interpretation is consistent with laboratory
data showing that a given UV dose delivered in multiple irradia-
tion sessions (dose fractionation) or over a longer period of time
(dose attenuation) is more efficient in causing skin tumours in
mice (Forbes; 1981; Kelfkens et al, 1991).
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